Beijing Business Daily News (Reporter Yao Qian) On May 11, Kai-Fu Lee, Chairman and CEO of Innovation Works, said at the medical innovation trend sharing meeting that AI and automation have become the bottom layer of the increasingly frequent crossover of technologies. The “digital infrastructure” of China has brought more and more innovative breakthroughs with the intersection of technologies in various fields. The traditional medical and health track has also ushered in an inflection point of innovation driven by the two major platform technologies, ushering in the era of “medical + X”.
Artificial intelligence is based on data, and the traditional medical industry is now being digitized in an all-round way, including the informatization of medical processes, the recording of whole-process health data by wearable devices, and the massive biological data generated by new technologies. A large amount of data will become the “nutrient” of AI, generating valuable algorithms to assist doctors in diagnosis and treatment in disease early warning, diagnosis, treatment, monitoring, long-term management, etc. “Precision treatment plan.
With the help of massive amounts of structured and gold-standard closed-loop data, the life sciences track will continue to look for landing scenarios that conform to industry laws and have commercial value. “In 5 to 10 years, AI will also be implemented in various medical segments. For example, specific medical imaging with clinical and commercial scenarios, auxiliary drug research and development, multi-omics and precise diagnosis, individualized treatment, surgical robots and other existences In the field, China’s medical big health track will officially enter the ‘medical + X’ era.” Kai-fu Lee said.
Wu Kai, a partner of Innovation Workshop, believes that in the era of “medical + X”, it includes “medical + information technology”, “medical + automation technology”, “medical + material science” and “medical + wearable devices”. “Medical + X” is a new paradigm of life science innovation and growth that will cross the cycle and affect the next decade.